Valvular & structural heart disease
A randomised multicentre study of angiography- versus physiologyguided percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation (TAVI): design and rationale of the FAITAVI trial
Study context
- Population
- Patients with significant coronary artery disease (CAD) (stenosis ≥50% by visual estimation in vessels ≥2.5 mm) and severe aortic valve stenosis undergoing TAVIplanned sample size
- Participants
- 320 patients
- Planned comparison
- Angiography-guided vs physiology-guided percutaneous coronary intervention (PCI) in patients undergoing TAVI
- Primary endpoint
- Composite of:
- Death
- MI
- Stroke
- Major bleeding
- Ischaemia-driven target vessel revascularisation
- Follow-up
- 12 months
Methodological detailsdesign and rationale, prospective, open-label, multicentre, nationwide, 15 sites in Italy, TAVI indication, strategy and medical treatment the same in both groups, Follow-up contacts at 1, 6, 12 and 24 months after the procedure
- Design and rationale
- Prospective
- Open-label
- Multicentre
- Nationwide
- 15 sites in Italy
- TAVI indication, strategy and medical treatment the same in both groups
- Follow-up contacts at 1, 6, 12 and 24 months after the procedure
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
A randomised multicentre study of angiography- versus physiologyguided percutaneous coronary intervention in patients with coronary artery disease undergoing TAVI: design and rationale of the FAITAVI trial. EuroIntervention. Published 15 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →